文献速递心律失常

智能手表单导联心电图设备检测心房颤动的准确性

Accuracy of a smartwatch based single-lead electrocardiogram device in detection of atrial fibrillation.
PubMed 文献 · Heart · 2020-01-07

这项前瞻性多中心验证研究在住院患者中评估AliveCor KardiaBand智能手表设备自动诊断心房颤动(AF)与12导联心电图的准确性。在200例患者中,设备诊断AF的敏感度94.4%、特异度81.9%,阳性预测值54.8%、阴性预测值98.4%,与12导联心电图一致性中等(κ=0.60)。结合电生理学家对未分类 tracings 的判读可提高一致性。

要点

  • KardiaBand自动诊断AF的敏感度94.4%、特异度81.9%,阴性预测值高(98.4%)。
  • 与12导联心电图一致性中等(κ=0.60,95%CI 0.47-0.72)。
  • 电生理学家判读未分类 tracings 可改善一致性(κ最高0.76)。

核心结论

  • KardiaBand与12导联心电图相比具有中等诊断准确性。
  • 自动诊断结合电生理学家对未分类 tracings 的判读可提高准确性。
  • 即使未来算法改进,医生参与可能仍是心律失常筛查的必要环节。

研究设计与样本

  • 前瞻性、多中心、验证性研究,在住院环境中进行。
  • 共纳入200例患者(AF 38例,窦性心律162例),来自三家三级中心,记录439份心电图(iECG 239份,12导联心电图200份)。

主要发现

  • KardiaBand诊断AF的敏感度94.4%,特异度81.9%。
  • 阳性预测值54.8%,阴性预测值98.4%。
  • 纳入未分类 tracings 时,12导联心电图与KardiaBand诊断一致性中等(κ=0.60,95%CI 0.47-0.72)。
  • 结合电生理学家判读未分类 tracings 后,一致性提高(EP1:κ=0.76,95%CI 0.65-0.87;EP2:κ=0.74,95%CI 0.63-0.86)。

临床怎么用

  • 该设备阴性预测值高,可能有助于排除AF,但阳性预测值较低,阳性结果需进一步确认。
  • 对设备未分类的 tracings 建议由医生判读以提高诊断准确性。

局限性

  • 研究在住院环境中进行,可能限制推广至一般人群或门诊筛查场景。
  • 未分类 tracings 需额外判读,自动化算法仍有改进空间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The AliveCor KardiaBand (KB) is an Food and Drug Administration-approved smartwatch-based cardiac rhythm monitor that records a lead-Intelligent ECG (iECG). Despite the appeal of wearable integrated ECG devices, there is a paucity of data evaluating their accuracy in diagnosing atrial fibrillation (AF). We evaluated whether a smartwatch-based device for AF detection is an accurate tool for diagnosing AF when compared with 12-lead ECG. METHODS: A prospective, multi-centre, validation study was conducted in an inpatient hospital setting. The KB paired with a smartwatch, generated an automated diagnosis of AF or sinus rhythm (SR). This was compared with a 12-lead ECG performed immediately after iECG tracing. Where an unclassified or no-analysis tracing was generated, repeat iECG was performed. RESULTS: 439 ECGs (iECGs (n=239) and 12-lead ECG (n=200)) were recorded in 200 patients (AF: n=38; SR: n=162) from three tertiary centres. Sensitivity and specificity using KB was 94.4% and 81.9% respectively, with a positive predictive value of 54.8% and negative predictive value of 98.4%. Agreement between 12-lead ECG and KB diagnosis was moderate when unclassified tracings were included (κ=0.60, 95% CI 0.47 to 0.72). Combining the automated device diagnosis with blinded electrophysiologists (EP) interpretation of unclassified tracings improved overall agreement (EP1: κ=0.76, 95% CI 0.65 to 0.87; EP2: κ=0.74, 95% CI 0.63 to 0.86). CONCLUSION: The KB demonstrated moderate diagnostic accuracy when compared with a 12-lead ECG. Combining the automated device diagnosis with EP interpretation of unclassified tracings yielded improved accuracy. However, even with future improvements in automated algorithms, physician involvement will likely remain an essential component when exploring the utility of these devices for arrhythmia screening. CLINICAL TRIAL REGISTRATION: URL: https://www.anzctr.org.au/ Unique identifier: ACTRN12616001374459.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Rajakariar K, Koshy AN, Sajeev JK, et al. Accuracy of a smartwatch based single-lead electrocardiogram device in detection of atrial fibrillation. Heart. 2020. PMID: 31911507. doi:10.1136/heartjnl-2019-316004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。